Cargando…
Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms
Proteins can exist as multiple proteoforms in vivo, as a result of alternative splicing and single-nucleotide polymorphisms (SNPs), as well as posttranslational processing. To address their clinical significance in a context of diagnostic information, proteoforms require a more in-depth analysis. Ma...
Autores principales: | Trenchevska, Olgica, Nelson, Randall W., Nedelkov, Dobrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217360/ https://www.ncbi.nlm.nih.gov/pubmed/28248223 http://dx.doi.org/10.3390/proteomes4010013 |
Ejemplares similares
-
Targeted quantitative mass spectrometric immunoassay for human protein variants
por: Trenchevska, Olgica, et al.
Publicado: (2011) -
Mass Spectrometric Immunoassay for the qualitative and quantitative analysis of the cytokine Macrophage Migration Inhibitory Factor (MIF)
por: Sherma, Nisha D, et al.
Publicado: (2014) -
Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes
por: Nedelkov, Dobrin
Publicado: (2017) -
The association of plasma cystatin C proteoforms with diabetic chronic kidney disease
por: Yassine, Hussein N., et al.
Publicado: (2016) -
The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
por: Yassine, Hussein N., et al.
Publicado: (2015)